Gastroenterology

Daklinza-Sovaldi produces similar SVR as Epclusa for HCV genotypes 2, 3





Daklinza with Sovaldi and ribavirin produced similar rates of sustained virologic response among patients with hepatitis C genotypes 2 and 3 as those treated with Epclusa, according to a recently published study.
“Genotype 2 accounts for 11% of chronic HCV infections both worldwide and in the United States, while genotype 3 accounts for 18% of HCV infections worldwide and 9% in the United States,” Pamela S. Belperio, PharmD, BCPS, from the Department of Veterans Affairs in California, and colleagues wrote. “In difficult-to-treat populations where less evidence-based guidance

Source link






WordPress database error: [Error writing file '/tmp/MYpUWk7k' (Errcode: 28 - No space left on device)]
SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (86284) AND ( wp_term_relationships.term_taxonomy_id IN (37) ) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish') GROUP BY wp_posts.ID ORDER BY RAND() LIMIT 0, 3

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy